Zenyu Shiokawa

This inventor holds 12 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 6 EPO patents. Top assignees: Takeda Pharmaceutical Company Limited, Cardurion Pharmaceuticals, LLC, Solent Therapeutics, LLC. Active years: 2013-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Zenyu Shiokawa. Retrieved from https://idiyas.com/inventor/zenyu-shiokawa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 4)

% Patents Active = 100.0

CIPO Patents = 2 (Patent Applications = 4)

EPO Patents = 6 (Patent Applications = 8)

Average Co-Inventor Count = 10.1

ph-index = 3

Forward Citations = 27(Granted Patents)

Location History:

Kanagawa, JP (2013 - 2023)
Fujisawa Kanagawa, JP (2021 - 2023)

Company Filing History:

6 out of 1,226

Takeda Pharmaceutical Company Limited

patents

5 out of 11

Cardurion Pharmaceuticals, LLC

patents

1 out of 1

Solent Therapeutics, LLC

patent

Years Active: 2013-2026

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12528816 - Substituted imidazo [1,2-b] pyridazines and [1, 2, 4] triazolo [ 4,3-b] pyridazines as camkii inhibitors (2026-01-20),

2. 12247015 - 3-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives as inhibitors of MRGX2 (2025-03-11),

3. 12171777 - Methods of making a cyclic dinucleotide (2024-12-24),

4. 11795172 - Substituted imidazo[1,2-b]pyridazines and [1,2,4]triazolo[4,3-b]pyridazines as CaMKII inhibitors (2023-10-24),

5. 11666594 - Antibody-drug conjugates comprising a cyclic dinucleotide (2023-06-06),

6. 11197858 - Substituted amines for treating cardiac diseases (2021-12-14),

7. 11130752 - Aminopyrimidine compound (2021-09-28),

8. 10980825 - Cyclic dinucleotide (2021-04-20),

9. 10543212 - Substituted amines for treating cardiac diseases (2020-01-28),

10. 9890145 - Heterocyclic compound (2018-02-13),

11. 9321757 - Heterocyclic compound (2016-04-26),

12. 8486965 - Pyrrolo[2,3-b]pyridine derivative and use thereof for treatment of cancer (2013-07-16),

Title: Zenyu Shiokawa - Innovator in Pharmaceutical Chemistry

Introduction

Zenyu Shiokawa, an accomplished inventor based in Kanagawa, Japan, has made significant contributions to the field of pharmaceutical chemistry. With a robust portfolio of 11 patents, his work primarily focuses on the development of innovative compounds that address critical health challenges.

Latest Patents

One of Zenyu Shiokawa's notable recent patents involves the synthesis of 3-amino-4H-benzo[e][1,2,4]thiadiazine 1,1-dioxide derivatives. These compounds serve as inhibitors for MRGX2, and the patent discloses various methods for preparing these compounds, including their use in treating diseases associated with MRGX2. Additionally, he has patented methods for creating cyclic dinucleotides, a class of compounds that exhibit STING agonistic activity, potentially paving the way for novel treatments for STING-related diseases.

Career Highlights

Throughout his career, Zenyu Shiokawa has worked with reputable organizations, including Takeda Pharmaceutical Company Limited and Cardurion Pharmaceuticals, LLC. His experience in these companies has not only honed his skills in patentable innovations but also contributed to the advancement of therapeutic solutions in the pharmaceutical industry.

Collaborations

In his journey, Zenyu has collaborated with talented professionals including Akito Shibuya and Yusuke Tominari. Their combined expertise has driven forward the development of innovative solutions aimed at addressing pressing health conditions, showcasing the power of teamwork in scientific advancements.

Conclusion

Zenyu Shiokawa stands out as a noteworthy inventor in the realm of pharmaceutical chemistry. His ongoing innovative research and developments through his patents continue to hold promise for improving health outcomes and advancing therapeutic strategies. As the field of medicine evolves, the contributions of inventors like Shiokawa will undoubtedly play a crucial role in shaping the future of healthcare.

Profile summary based on public USPTO records.